OAZ Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of OAZ Antibodies for the specific detection and analysis of ornithine decarboxylase antizyme (OAZ). OAZ Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).OAZ plays a critical role in regulating polyamine synthesis by inhibiting ornithine decarboxylase, an enzyme involved in cell growth and differentiation. The regulation of polyamines is essential for cellular functions, including cell proliferation, apoptosis, and gene expression. Understanding OAZ dynamics is vital for elucidating implications in cancer biology and other diseases associated with dysregulated polyamine metabolism. Researchers worldwide utilize OAZ monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms. Advanced research techniques incorporating OAZ monoclonal antibodies enable detailed examination of protein interactions and expression patterns. Current studies focusing on OAZ continue to reveal new insights into cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies for OAZ support researchers in advancing scientific understanding of polyamine metabolism and its role in human health and disease.